DK134488B - Analogifremgangsmåde til fremstilling af i stillingerne 4a, 10b cis-konfigurerede benzo/c//1,6/naphthyridinderivater eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af i stillingerne 4a, 10b cis-konfigurerede benzo/c//1,6/naphthyridinderivater eller syreadditionssalte deraf.

Info

Publication number
DK134488B
DK134488B DK225771A DK225771A DK134488B DK 134488 B DK134488 B DK 134488B DK 225771 A DK225771 A DK 225771A DK 225771 A DK225771 A DK 225771A DK 134488 B DK134488 B DK 134488B
Authority
DK
Denmark
Prior art keywords
benzo
cis
positions
preparation
acid addition
Prior art date
Application number
DK225771A
Other languages
Danish (da)
English (en)
Other versions
DK134488C (OSRAM
Inventor
Hans Ott
Rudolf Sueess
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH708670A external-priority patent/CH527196A/de
Priority claimed from CH708970A external-priority patent/CH527822A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK134488B publication Critical patent/DK134488B/da
Application granted granted Critical
Publication of DK134488C publication Critical patent/DK134488C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK225771A 1970-05-13 1971-05-11 Analogifremgangsmåde til fremstilling af i stillingerne 4a, 10b cis-konfigurerede benzo/c//1,6/naphthyridinderivater eller syreadditionssalte deraf. DK134488B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH708670A CH527196A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphthyridinderivate
CH708970A CH527822A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate

Publications (2)

Publication Number Publication Date
DK134488B true DK134488B (da) 1976-11-15
DK134488C DK134488C (OSRAM) 1977-05-16

Family

ID=25700728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225771A DK134488B (da) 1970-05-13 1971-05-11 Analogifremgangsmåde til fremstilling af i stillingerne 4a, 10b cis-konfigurerede benzo/c//1,6/naphthyridinderivater eller syreadditionssalte deraf.

Country Status (14)

Country Link
JP (1) JPS5432799B1 (OSRAM)
AT (1) AT326674B (OSRAM)
CA (1) CA970377A (OSRAM)
CS (2) CS162753B2 (OSRAM)
DE (1) DE2123328A1 (OSRAM)
DK (1) DK134488B (OSRAM)
ES (1) ES391026A1 (OSRAM)
FI (1) FI52089C (OSRAM)
FR (1) FR2100649B1 (OSRAM)
GB (1) GB1361441A (OSRAM)
NL (1) NL7106502A (OSRAM)
PL (1) PL76913B1 (OSRAM)
SE (1) SE387640B (OSRAM)
SU (1) SU423296A3 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
NL7314396A (OSRAM) * 1972-10-26 1974-05-01
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine
ATE232864T1 (de) 1997-06-03 2003-03-15 Altana Pharma Ag Benzonaphthyridine
AU777012B2 (en) 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
MXPA06013162A (es) * 2004-05-12 2007-02-13 Pfizer Prod Inc Derivados de piperidina como antagonistas de neurocinina 1 y neurocinina 3.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
HK1220696A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 鸟苷酸环化酶激动剂及其用途
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Also Published As

Publication number Publication date
NL7106502A (OSRAM) 1971-11-16
ES391026A1 (es) 1974-04-01
FR2100649B1 (OSRAM) 1974-08-30
SU423296A3 (ru) 1974-04-05
DK134488C (OSRAM) 1977-05-16
CA970377A (en) 1975-07-01
FR2100649A1 (OSRAM) 1972-03-24
FI52089C (fi) 1977-06-10
SE387640B (sv) 1976-09-13
CS167202B2 (OSRAM) 1976-04-29
AT326674B (de) 1975-12-29
DE2123328A1 (de) 1971-12-02
GB1361441A (en) 1974-07-24
JPS5432799B1 (OSRAM) 1979-10-16
PL76913B1 (en) 1975-02-28
FI52089B (OSRAM) 1977-02-28
ATA412471A (de) 1975-03-15
CS162753B2 (OSRAM) 1975-07-15

Similar Documents

Publication Publication Date Title
DK123600B (da) Analogifremgangsmåde til fremstilling af i 11-stillingen substituerede 5, 11-dihydro-6H-pyrido [2,3-b] [1,4] benzodiazepin-6-oner eller syreadditionssalte heraf.
DK124547B (da) Analogifremgangsmåde til fremstilling af (3-amino-2-hydroxy-propyloxy)-thiochromanderivater eller syreadditionssalte deraf.
DK134488B (da) Analogifremgangsmåde til fremstilling af i stillingerne 4a, 10b cis-konfigurerede benzo/c//1,6/naphthyridinderivater eller syreadditionssalte deraf.
DK125794B (da) Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
DK123775B (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-azepino[4,5-b]indolderivater eller syreadditionssalte deraf.
DK138324B (da) Analogifremgangsmåde til fremstilling af piperazinsubstituerede isoindolinderivater eller syreadditionssalte deraf.
DK135278B (da) Analogifremgangsmåde til fremstilling af fenoksyisopropanolaminderivater eller syreadditionssalte deraf.
DK130213B (da) Analogifremgangsmåde til fremstilling af 9-(4-piperidyliden) thioxanthenderivater eller syreadditionssalte deraf.
DK131721B (da) Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf.
DK137382B (da) Analogifremgangsmåde til fremstilling af 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidin)butyramider eller syreadditionssalte deraf.
DK125245B (da) Fremgangsmåde til fremstilling af γpiperidinobutyrophenonderivater eller syreadditionssalte deraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK131857B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf.
DK135231B (da) Analogifremgangsmåde til fremstilling af basisk substituerede 2,3-cis, trans-diphenylcyclopropanderivater eller syreadditionssalte deraf.
DK127424B (da) Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf.
DK137044B (da) Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf.
DK138748B (da) Analogifremgangsmåde til fremstilling af lincomycin-derivater eller syreadditionssalte deraf.
DK138690B (da) Analogifremgangsmåde til fremstilling af 5,6-dihydropyrrolo(3,4-b)pyridinderivater eller syreadditionssalte deraf.
DK139973B (da) Analogifremgangsmåde til fremstilling af s-triazolo-(4,3-a)(1,4)-benzodiazepinderivater eller syreadditionssalte deraf.
DK125175B (da) Analogifremgangsmåde til fremstilling af lysergsyre- eller 9,10-dihydrolysergsyrederivater eller syreadditionssalte heraf.
DK127431B (da) Analogifremgangsmåde til fremstilling af thiepinderivater eller syreadditionssalte deraf.
DK136367B (da) Analogifremgangsmåde til fremstilling af indolderivater eller farmaceutisk acceptable syreadditionssalte deraf.
DK137834B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepinderivater eller syreadditionssalte deraf.
DK139943B (da) Fremgangsmåde til fremstilling af triazolo(4,3a)(1,4)benzodiazepin-5N-oxydderivater eller syreadditionssalte deraf.